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1. This report is submitted as a follow-up to the pledges I made during the Joint 
African Union (AU) Commission – Permanent Representatives’ Committee (PRC) 
Retreat, held in Cairo, Egypt, from 10 to 11 December 2017, and the interaction I had 
with the PRC on 7 March 2018. The report highlights the efforts of the Commission to 





2. Livestock production in Africa is affected by several factors. Animal diseases 
constitute the major constraint of efficient production of livestock, as they threaten the 
livelihoods of livestock producers and food security. They result in increased mortality 
and morbidity in livestock populations. They may also affect performance through 
reduced fertility, delays in reaching maturity for reproduction or sale, decreased 
production of milk, eggs and wool, decreased draught power, and decreased weight 
of fattening or cull animals.  
 
3. Several methods are used for the treatment, prevention and control of livestock 
disease. While the stamping out method, vaccination and the therapeutic or 
prophylactic use of drugs all play important roles in animal disease control, in the 
African context, vaccination is considered as the most appropriate choice because it 
is less costly and less likely to result in disease resistance in the field. It is, therefore, 
very important that the vaccines given to animals for the control of disease are of very 
good quality. 
 
4. The concept of independent quality control of veterinary vaccines used in Africa 
started in the early 80s as a prerequisite to fund the Pan-African Rinderpest Campaign 
(PARC). The audit conducted on the quality of Rinderpest vaccines produced in Africa 
by the Food and Agriculture Organization of the United Nations (FAO) in 1983 
indicated serious deficits in quality, as only 20% of the vaccines produced by African 
laboratories were of good quality.  
 
5. As a recommendation from this survey, the FAO Expert Consultation on 
Rinderpest held in Rome, in October 1984, urged all vaccine producing laboratories 
to participate in the implementation of an international and independent vaccine quality 
control scheme. In 1986, FAO, through its Technical Cooperation Programmes, 
established two Regional Vaccine Quality Control and Training Centres in Debre-Zeit 
(Ethiopia) and Dakar (Senegal), which are dedicated to improving the quality of 
Rinderpest vaccines produced in Africa to support the PARC. This was followed, from 
1988 to 1993, by an initiative funded by the United Nations Development Programme 
(UNDP), which resulted in the merger of the two Centres into a single structure, which 
became the Pan-African Veterinary Vaccine Centre (PANVAC) to reflect its Pan-
African nature.  
 





6. In recognition of the important role played by PANVAC to certify the quality of 
vaccines for the control and eradication of Rinderpest in Africa, PANVAC was elevated 
to a Specialized Agency of the Organisation of African Unity (OAU) by the OAU 
Council of Ministers during the 67th Ordinary Session held in Addis Ababa, from 23 to 
27 February 1998. PANVAC was officially launched as an AU Regional Centre, with 
its headquarters based at Debre Zeit, in 2004. The mandate entrusted to the new 
Centre, hereto called AU-PANVAC, was extended to quality control of all veterinary 
vaccines, as well as to the production of diagnostic tests for surveillance and control 
of animal diseases.  
 
7. Following the major role it played during the eradication programme of 
Rinderpest, PANVAC mandate was reviewed as follows: 
 
i. international independent quality control of veterinary vaccines produced in 
Africa and imported for use in Africa; 
 
ii. production and distribution of essential biological reagents for diagnosis and 
surveillance of animal disease; 
 
iii. standardization and harmonization of veterinary vaccines production and 
their quality control techniques in Africa; 
 
iv. promotion of transfer of appropriate vaccine production technologies in 
Africa; and 
 
v. provision of  training and technical support services to veterinary vaccines 
and quality control laboratories. 
 
8. From the mandate stated above, two major activities are currently conducted 
by PANVAC, with the aim of providing appropriate tools to Member States for the 
surveillance, control and prevention of animal diseases: 
 
i. quality control of all veterinary vaccines produced and imported for use in 
Africa; and 
 
ii. production and distribution of essential diagnostic reagents for surveillance 
of animal diseases. 
 
9. PANVAC has also been given the following specific tasks: 
 
i. maintaining Africa free from Rinderpest, through the sequestration of all 
Rinderpest material from African laboratories, and maintaining an 
emergency vaccine stock; and 
 
ii. harmonization of veterinary vaccine registration on the continent. 
 
III. PANVAC’S MAJOR ACHIEVEMENTS 
 
Promote the use of good quality vaccine in Africa for control and 
prevention of animal diseases 
 





10. During its previous phases, PANVAC’s principal objective has been to promote 
improvements in the quality of veterinary vaccines, with the intention of achieving 
uniformly high standards of production and quality control of essential veterinary 
vaccines.  
 
11. PANVAC’s achievements in the Rinderpest control and eradication programme 
have been well appreciated and recognized by various evaluation and review teams, 
consultants, beneficiary laboratories and Governments. The final evaluation report of 
PARC and PACE stated that: “The success of the Pan-African Rinderpest Campaign 
and the Pan-African Programme for the Control of Epizootics clearly demonstrated 
that no amount of vehicles, syringes, trained personnel, communication materials 
would have eliminated Rinderpest if the vaccine batches used were of poor quality. 
The secondary and independent level of quality control assessment assured by 
PANVAC played a major role for this success and led, at the same time, to a sustained 
improvement in the quality of vaccines against Rinderpest and Contagious Bovine 
Pleuropneumonia produced in Africa”. 
 
12. The impact of PANVAC activities in control of vaccine quality can be measured 
by the following: 
 
i. PANVAC annually tests more than 1 billion vaccine doses (1,000,000,000) 
for the protection of 1 billion animals (all species). It is estimated that 90% 
of all meat consumed in Africa is likely to be from livestock treated with 
vaccines certified by PANVAC; and 
 
ii. the pass rate of vaccines tested by PANVAC has increased from 20% in the 
eighties to around 90% presently.  
 
13. In recognition of the role of PANVAC in the certification of veterinary vaccines, 
it was designated as a World Organisation for Animal Health (OIE) Collaborating 
Centre and FAO Reference Centre for Quality Control of Vaccines. 
 
Strengthen the capacities of African laboratories 
 
14. PANVAC has trained over 1,000 Veterinarians and Technicians from National 
Vaccine Production Laboratories in Africa. PANVAC is also providing technical 
expertise to vaccine producing and diagnostic laboratories.  
 
15. Technical support is also provided to AU Members States for diagnosis and 
surveillance of animal diseases. PANVAC recently assisted Liberia and Burundi to 
diagnose the Peste des Petits Ruminants disease, which killed more than 4,000 
animals (sheep and goat) in each of these two countries. 
 
Maintaining an Africa free from Rinderpest  
 
16. Following the recommendations from the 8th Conference of the Ministers 
responsible for Animal Resources held in 2011, in Entebbe (Uganda), for AU Member 
States to destroy Rinderpest virus strains stored in African laboratories and the 
handing over of the material deemed necessary to PANVAC for safe storage, 
PANVAC acquired a Bio-Safety Laboratory Level 3 (BSL3), which was inaugurated in 
2011.  
 





17. An inspection of PANVAC facilities was conducted in 2015 by international 
experts designated by OIE and FAO. Following their recommendations, PANVAC was 
designated as one of the four Rinderpest holding facilities in the world by FAO and the 
IOE (the three other Centres are located in Japan, the United Kingdom and the United 
States of America). PANVAC is the only Centre in the world certified to hold Rinderpest 
field and vaccine strains in the same facility. 
 
18. PANVAC has set up a continental vaccine bank that aims at ensuring 
emergency preparedness to respond to any possible outbreak of Rinderpest and other 
animal diseases in Africa. This facility has the capacity to store 15 million doses of 
vaccine. I officially inaugurated the Bank on 31 January 2018, in the presence of the 
Commissioner in charge of Rural Economy and Agriculture, the Ethiopian Minister of 
State for Livestock and Fisheries, members of the diplomatic corps, representatives 
of African vaccine producing laboratories and Directors of Veterinary Services, as well 
as the Head of FAO Liaison Office to the AU. I also look the opportunity to unveil the 
Memorial for Riderpest Eradication. 
 
Development and production of diagnostic reagents 
 
19. A framework for the production and distribution of diagnostic reagents to 
support surveillance of priority animal diseases in Africa was developed with the 
participation of Members States. In line with this document, PANVAC has developed 
various biological reagents and diagnostic tests for distribution to Member States, 
namely: 
 
i. diagnostic tests for the Peste des Petits Ruminants disease, which is the one 
of the most devastating diseases of small ruminants (sheep and goats). This 
test was validated according to international standard and will contribute to 
reduce, by 75%, the cost of the diagnosis and surveillance activities of this 
disease in AU Member States; and 
 
ii. other diagnostic tests to support the surveillance and control of other diseases 
in small ruminants (sheep and goat). 
 
Certification of PANVAC in Quality Management System (ISO 9001: 2015) 
 
20. PANVAC has successfully implemented quality management system (ISO 
9001:2015) which has been certified by a German quality audit and certification 
company (DQS) based in Ethiopia. This certification enables PANVAC to continually 
improve the quality of vaccine quality control services and biological reagent 




21. While remarkable gains have been made, PANVAC faces a number of 
challenges. These need to be addressed in earnerst. 
 
Inadequate staff  
 
22. Currently, PANVAC only has 5 regular technical staff and 5 short-term staff 
supported by partners. Due to the overload of activities, it is necessary to recruit at 
least 10 additional technical staff to support the activities of PANVAC. 








23. The current facilities of PANVAC should be improved in terms of 
biosafety/biosecurity. There is need to establish a New Standard and Befitting 
Laboratory Facility. Its total cost is estimated at 10 million dollars. 
 
 Need to increase the stock of Continental vaccine bank 
 
24. The current Rinderpest emergency vaccine stock of 1.5 million doses should 
be increased. Resources need to be mobilized to procure an additional 10 million 
doses to meet continental demand. 
 
V. OBSERVATIONS AND RECOMMENDATIONS 
 
25. Livestock plays a crucial role in Africa’s development and the wellbeing of its 
people. Against this backdrop, I would like to underline the Commission’s commitment 
to deepen its efforts towards the control of animal diseases on the continent. I 
commend PANVAC, as well as the Nairobi-based Inter-African Bureau of Animal 
Resources (IBAR), for their contributions. 
 
26. We can take legitimate pride in the achievements of PANVAC in the discharge 
of its mandate to provide international independent quality control for all veterinary 
vaccines produced or imported in Africa. It is one of the four Rinderpest holding 
facilities certified in the world by FAO and OIE. PANVAC is the only Centre in the world 
authorized to hold, in the same facility, Rinderpest wild strain and vaccine strains. 90 
per cent of meat consumed in Africa is likely to be from livestock treated with vaccines 
certified by PANVAC. I witnessed by myself the outstanding work of PANVAC when I 
visited its Headquarters to inaugurate the Continental Veterinary Vaccine Bank and 
unveil the Memorial for Rinderpest Eradication. Taking PANVAC as a model, FAO and 
Asian countries are planning to establish a similar vaccine quality control centre to 
support their programme for the eradication Peste des Petits Ruminants disease. 
 
27. No effort should be spared to provide PANVAC with the resources it needs for 
the implementation of its mandate. While efforts to reach out to partners to seek further 
assistance will continue, it is essential that Member States also contribute in whatever 
way possible to the efforts being spearheaded by PANVAC. 
 
28. I express gratitude to the Government of the Federal Democratic Republic of 
Ethiopia for its unwavering support to PANVAC and for the close collaboration with 
Ethiopia’s National Veterinary Institute. I also commend international partners 
providing support to PANVAC, in particular FAO, OIE, the EU, the Gates Foundation, 
the United States Agency for International Development and the Global Alliance for 
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